Trial intelligence / Profile preview

Tolerability of Duac vs Epiduo in Acne Vulgaris

NCT00964223Phase 4Completed

Sponsor
GSK
Start
Jul 2009
Primary completion
Nov 2009
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of clindamycin + benzoyl peroxide in acne vulgaris, sponsored by GSK. Started Jul 2009; status: completed.

02

Drugs

clindamycin + benzoyl peroxide
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00964223.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00964223.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call